In a study investigating the functional effects of ST3Gal-III in cisplatin-resistant ovarian cancer cells, it was revealed that cisplatin-resistant HO8910PM cells with high invasive and metastatic capacity presented elevated ST3Gal-III expression. Here, ST3GAL3 is linked to ovarian carcinoma.